School of Pharmacy , Guangdong Pharmaceutical University , Gaungzhou , 510006 , China.
Guangdong Province Engineering Technology Centre for molecular Probe & Bio-medicine Imaging , Guangdong Pharmaceutical University , Guangzhou 510006 , China.
J Med Chem. 2018 Dec 13;61(23):10488-10501. doi: 10.1021/acs.jmedchem.8b01018. Epub 2018 Nov 19.
Tanshinone-IIA (Tan-IIA), a primary active component extracted from commonly used Chinese herbal, Salvia miltiorrhiza (Danshen), is considered as a potential inhibitor against tumor cell proliferation. However, the potential application of Tan-IIA is hindered by its poor water solubility and low bioavailability. In this work, an imidazole moiety was linked to the skeleton of Tan-IIA to enhance its antitumor activity. A series of Tan-IIA-based analogues TA01-TA12 were synthesized, and their inhibitory activities against the migration and invasion of MDA-MB-231 cells were investigated. All compounds, particularly TA12, markedly inhibited the proliferation, migration, and invasion of MDA-MB-231cells. TA12 also prominently blocked cancer cell metastasis in blood vessels and surrounding tissues in zebrafish xenograft model. Further studies showed that the mechanisms may involve S-phase arrest pathway, which was probably caused by inducing reactive oxygen species production and activating DNA damage. These results indicated that the Tan-IIA-based analogues of imidazole derivates can act as potent antimetastasis agents.
丹参酮 IIA(Tan-IIA)是从常用中药丹参中提取的主要活性成分之一,被认为是一种潜在的肿瘤细胞增殖抑制剂。然而,由于其水溶性差和生物利用度低,Tan-IIA 的应用受到限制。在这项工作中,将咪唑基团连接到 Tan-IIA 的骨架上,以增强其抗肿瘤活性。合成了一系列基于 Tan-IIA 的类似物 TA01-TA12,并研究了它们对 MDA-MB-231 细胞迁移和侵袭的抑制活性。所有化合物,特别是 TA12,显著抑制了 MDA-MB-231 细胞的增殖、迁移和侵袭。TA12 还明显阻断了斑马鱼异种移植模型中癌细胞在血管和周围组织中的转移。进一步的研究表明,这些机制可能涉及 S 期阻滞途径,这可能是由于诱导活性氧产生和激活 DNA 损伤所致。这些结果表明,基于 Tan-IIA 的咪唑衍生物类似物可以作为有效的抗转移剂。